Clinical and research tests for C1292778 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 4

Results: 1 to 20 of 61

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Myeloid Next Generation Sequencing with Reflex Pathology Interp Sentara Healthcare Laboratory Services United States	3	69	T Targeted variant analysis
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States	16	160	T Targeted variant analysis
Myeloid NextGen Sequencing Assay with Calreticulin Exon 9 Mutation PathGroup United States	16	65	T Targeted variant analysis
Myeloid NextGen Sequencing Assay PathGroup United States	16	65	T Targeted variant analysis
Myeloid NextGen Sequencing Assay with FLT3 ITD and TKD Analysis PathGroup United States	16	65	T Targeted variant analysis
Comprehensive Myeloid Profile + CALR PCR + FLT3 PCR PathGroup United States	16	65	T Targeted variant analysis
MarrowZoom Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States	249	155	C Sequence analysis of the entire coding region
Calreticulin Exon 9 Mutation, JAK2 V617F Quant and Exons 12-15 and MPL Mutation Analysis PathGroup United States	9	3	T Targeted variant analysis
JAK2 V617F Mutation Detect and Quant and JAK2 Exons12-15 Mutation Analysis PathGroup United States	5	1	T Targeted variant analysis
Calreticulin Exon 9 Mutation, MPL Mutation analysis and JAK2 Exons12-15 Mutation Analysis PathGroup United States	9	3	T Targeted variant analysis
Calreticulin Exon 9 Mutation and MPL Mutation analysis PathGroup United States	8	2	T Targeted variant analysis
Calreticulin Exon 9 Mutation and JAK2 V617F Quant and Exons 12-15 PathGroup United States	8	2	T Targeted variant analysis
Calreticulin Exon 9 Mutation, MPL and JAK2 V617F Quant PathGroup United States	9	3	T Targeted variant analysis
Calreticulin Exon 9 Mutation and JAK2 V617F Quant PathGroup United States	8	2	T Targeted variant analysis
HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and T-Cell Clonality Analysis PathGroup United States	23	160	T Targeted variant analysis
HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and JAK2 V617F Quant PathGroup United States	18	160	T Targeted variant analysis
Calreticulin Exon 9 Mutation and FLT3 ITD and TKD Analysis PathGroup United States	7	2	T Targeted variant analysis
Calreticulin Exon 9 Mutation and FLT3 ITD and TKD Analysis PathGroup United States	7	2	T Targeted variant analysis
Calreticulin Exon 9 Mutation and FLT3 ITD and TKD Analysis PathGroup United States	7	2	T Targeted variant analysis
BCR/ABL IS Quant CML and JAK2 V617F Quant and JAK2 Exon 12-15 PathGroup United States	7	3	T Targeted variant analysis

<< First< Prev

Page 1 of 4

Results: 1 to 20 of 61

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.